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The epithelium is the first line of defense against noxious
environmental stimuli through different barrier mechanisms.
These barrier mechanisms are maintained by various junc-
tions that can be broadly classified into tight junctions (TJ),
gap junctions and adherence junctions ( Dokladny et al. ,
2016). TJ acts as an occluding junction that seals the adja-
cent epithelial cells and prevent the paracellular passage of
small solutes and molecules. Adherence junctions are cal-
cium dependent attachment plaques which connects cell−cell
or cell − matrix via actin and intermediate filaments to
strengthen the cytoskeleton. Gap junctions are composed of
connexin proteins involved in connecting cells and create
channels to transport small molecules and ions between the
cells (Balda & Matter, 2008).
TJ is the most important epithelial barrier system, and
forms the continuous and circumferential belt like structures
at the apical compartment of epithelial sheets. This protein
complex is composed of integral membrane proteins that
constitute TJ strands, cytoplasmic proteins and cytoskeletal
proteins. It also has roles in maintaining cellular polarity,
cell differentiation and signal transduction (Gonzalez−Maris-
cal et al., 2003)
The junctional proteins of TJ play a major role in holding
epithelial cells together (Buckley & Turner, 2018). Claudin,
occludin and junctional adhesion molecules (JAM) are the
integral junctional proteins of TJ ( Chiba et al. , 2008 ) .
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Abstract
The epithelium is the first line of defense against
noxious environmental stimuli through different barrier
mechanisms. These barrier mechanisms are maintained
by various junctions that can be broadly classified into
tight junctions (TJ), gap junctions and adherence junc-
tions. TJ is the most important epithelial barrier system
and forms a continuous, circumferential belt like struc-
tures at the apical compartment of epithelial sheets. The
junctional proteins of TJ play a major role in holding
epithelial cells together. The integral junctional proteins
of TJ are claudin and occludin. Claudin and occludin
have been shown to alter in various diseases of skin
and oral mucosa. Also, their alteration with aging has
been demonstrated to cause poor epithelial barrier func-
tion. Although, various studies have been focused on
claudin and occludin, the findings are dispersed. In this
review, we summarize the altered expression of the TJ
proteins, claudin and occludin, in different pathological
conditions including carcinoma of skin and oral mu-
cosa. Also, we summarize the changes in these proteins
with aging in both skin and oral mucosa. The findings
of our review suggest that the altered expression, not
alone downregulation or upregulation of these proteins
are responsible for causing various epithelial barrier re-
lated skin and oral diseases. The role of these proteins
is crucial in the invasion and metastasis of various car-
cinomas. The understanding of altered expression of
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Claudin and occludin are the backbone in forming TJ
strands, whereas JAM is not essential to TJ formation in epi-
thelial cells but involved in various biologic processes like
inflammatory reactions and tumorigenesis (Reglero−Real et
al., 2016).
Claudin and occludin have been shown to alter in various
diseases of skin and oral mucosa. Their alterations with ag-
ing have been demonstrated to cause poor epithelial barrier
function (Saitoh et al., 2009). Although various studies have
been focused on claudin and occludin, the results so far are
controversial. In this review, we summarize the altered ex-
pression of claudin and occludin in different pathological
conditions, carcinoma and aging of skin and oral mucosa.
Role of TJ proteins in barrier mechanism and
its regulation
TJ is the apical component of cell membrane in polarized
epithelium and endothelium, which is involved in the cell−
cell interactions at the lateral domains (Bauer et al., 2014).
Claudin, a 20−27kDa membrane protein, is composed of 27
members expressed in TJ of epithelial cells including skin
and oral mucosa (Günzel & Fromm, 2013) . Claudin is also
transmembrane protein which is composed of two intracellu-
lar N and C segment and two extracellular loops. The first
loop, with high content of tyrosine and glycine residues, is
responsible for paracellular charge selectivity. The second
loop, the carboxy terminal domain, rich in serine, threonine
and tyrosine residues is a target for a number of proteins
and tyrosine kinases, and acts as a co−receptor for bacterial
toxins (Weber, 2008). Paracellular flux is regulated by pore
pathway allowing passage to small ions and macromole-
cules, or leaky pathway which allows larger molecules to
pass through (Capaldo & Nusrat, 2009). Claudin−1, −3, −5,
−11 and −19 are considered as the sealing components, and
claudin −2, −10, −15 and −17 are considered as the channel
forming components of TJ (Bauer et al., 2014). Occludin, a
60kDa protein, has four transmembrane domains, three cyto-
plasmic domains (long COOH terminal, short NH2 terminal
domains and short intracellular turn), and two extracellular
loops (Förster, 2008). The C−terminal of the occludin plays
an essential role in paracellular channel formation, and N−
terminal is essential for TJ barrier functions and extracellular
loops helps to retain occludin to TJ strands ( Cummins. ,
2012). The C−terminal half of the occludin also binds with
peripheral membrane proteins like zona occludens (ZO) and
comprises ZO−1, −2 and −3. ZO proteins interact directly
with most of the transmembrane proteins including occludin
and claudin and acts as a scaffold which allows numerous
protein−protein interactions and a cross linker between cyto-
plasmic proteins and actin based cytoskeleton (Pummi et al.,
2001).
The structures of TJ is dynamic and is regulated by vari-
ous protein phosphorylation and dephosphorylation in re-
sponse to signaling molecules which determine the composi-
tional and functional integrity of TJ proteins. The disruption
of TJ is caused by the activation of various signaling pro-
teins such as MAPKs, Rho GTPase signaling mechanisms
and protease activator receptor in response to different nox-
ious stimuli such as oxidative stress, inflammatory media-
tors, growth factors (Enjoji et al., 2014). It has been shown
that the expression of claudin was increased and TJ assem-
bly was enhanced by the inhibition of PP 2 A ( McCole,
2013). The expression of specific genes, which are important
for epithelial differentiation and morphogenesis, is activated
by the subsequent translocation into the nucleus (Gottardi et
al., 1996) and are responsible for cellular differentiation, ac-
tin cytoskeleton regulation and TJ functions remodulation
(Matter & Balda, 2007).
TJ protein in healthy skin and oral mucosa
Skin is composed of several layers. Stratum corneum, the
uppermost layer mainly composed of keratinocytes, is the
first line of barrier to the environmental insults such as aller-
gen, microbiome, irritants and pollutants. Once the barrier
function of stratum corneum is compromised, the next bar-
rier is performed by TJ proteins, mainly claudin and oc-
cludin, in the stratum granulosum layer (Brandner et al. ,
2015). Oral mucosa is classified as keratinized or non−kera-
tinized tissue. The stratum corneum is absent from non−
keratinized tissue. In gingiva, the oral epithelium is kerati-
nized, sulcular epithelium is predominantly non−keratinized
and junctional epithelium is non−keratinized (Caffesse et al.,
1977). The role of TJ proteins becomes more critical in the
non−keratinized oral tissue including sulcular epithelium and
junctional epithelium. This might be a cause that sulcular
epithelium and junctional epithelium are especially affected
in periodontal diseases.
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Claudin and Occludin in different pathological
conditions of skin and oral mucosa
The altered expression of claudin and occludin are mostly
observed in various pathological conditions of skin depend-
ing on the severity of the disease, bacterial concentration
and epidermal differentiation (Table 1). Increased expression
of occludin and decreased expression of claudin−1 and 7 are
observed in the early or late stages of psoriasis with more
prominent effects in later (Brandner, 2002 ; Kirschner et al.,
2009). The expression of claudin−1, 2 and 3 are downregu-
lated in atopic dermatitis facilitating entry of pathogen
through epidermis, however compensatory mechanism to
maintain barrier integrity leads to the overexpression of
claudin−4 (Guttman et al. 2006). It is reported that TJ pro-
teins are altered in human epidermal keratinocytes during
different bacterial infections. A study showed that the in-
creased expression of TJ proteins as a rescue mechanism
was observed by the exposure of Staphylococcus aureus and
Staphylococcus epidermidis to epithelial cell for 3 hours,
while the significantly decreased expression was observed
by the exposure for 7−10 hours due to the loss of transepi-
thelial resistance (TER). No alteration of TJ proteins is ob-
served in the epithelial barrier by the exposure at the con-
centration of < 104 bacteria/ml for 5 hours, while downregu-
lated expression of claudin−1, 4 and 7 is observed by in-
creasing bacterial load up to the concentration of 106 bacte-
ria/ml (Ohnemus et al., 2008). Hailey−Hailey disease and
Darrier’s disease are autosomal dominant skin diseases
where alteration of TJ proteins is associated with epidermal
differentiation and calcium gradient. In both, increased ex-
pression of claudin−1, 4 and occludin is observed with the
Pathological
condition (Skin)
Proteins Explained Impact References

















Early rise of TJ proteins may be due to rescue mechanism
during bacteria−keratinocyte interaction.
Dyslocalization of TJ proteins occurred after bacteria invade
the epidermis.
(Ohnemus et al., 2008)








1) Broader expression of occludin and claudin is to keep
barrier functions results in thicker epidermal layer.
2) Further loss of claudin is a consequence of various stim-
uli like bacterial infections leading to impairment in the TJ
barrier functions.
( Brandner, 2002 ; Watson




Claudin − 4↑ (non − lesional
area)
1)Decreased Claudin−1,23 enhance the penetration of envi-
ronmental antigens leading to greater allergen sensitization.
2)Increased Claudin −4 is a compensatory mechanism to
maintain stratum corneum barrier integrity.
(Guttman et al., 2006 ; De
Benedetto et al., 2011)
Impetigo Contagiosa Occludin ↑
Claudin−1↓
Early rise of TJ proteins may be due to rescue mechanism.
Downregulation of TJ proteins occurred after bacteria in-
vade the epidermis.







Acantholytic process alters the dynamics of TJ proteins.
Altered expression of TJ may be due to aberrant epidermal
differentiation and calcium concentration.




Occludin↑ Alteration in stratum granulosum layer leads TJ proteins to
relocalize to stratum spinosum which results in hyperkera-
totic lesion.
(Pummi et al., 2001)
Darrier’s Disease Claudin−1↓ Acantholytic process alters the dynamics of TJ proteins
which highlight the importance of intercellular calcium in
TJ regulation.




Decreased Claudin−1 increases the paracellular permeability
due to poor anchoring among the claudin in epithelial cells.
The relative overexpression of claudin−2 in the patient liver
is due to compensatory mechanism.
(Hadj−Rabia et al., 2004)
Mouse−model Claudin−1 knockout Died immediately after birth due to transepidermal water
loss and skin dehydration.
(Furuse et al., 2002)
Table 1 : Altered expression of Claudin and Occludin in various skin diseases ; TJ, Tight Junction ; NISCH, Neonatal ichthyosis−scleros-
ing cholangitis.
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low calcium concentration while significant downregulations
were observed by increasing calcium gradient and epidermal
differentiation (Raiko et al., 2012).
In experimental models of periodontitis, the expression of
TJ proteins depends on the duration or the grade of peri-
odontitis, bacterial concentration and apical or basolateral
exposure in vitro . The expression of claudin − 4, 15 is
upregulated in case of biofilm challenge and minimally in-
flamed gingival epithelium for 24 hour (Guo et al., 2017)
while claudin−4, 15 and occludin is downregulated in pocket
epithelium. These suggest that the expression of TJ proteins
is decreased by the chronicity of diseases. Porphyromonas
gingivalis (Pg) along with its virulence factors is one of the
major etiologic agents in the pathogenesis and progression
of periodontal disease. Significant upregulation of claudin−4
is shown by the exposure of Pg to gingival epithelial cell
for 4 hours, with no effect on claudin−1 and occludin. In
contrast, the expression of claudin−4, 15 and occludin is
downregulated by the exposure of Pg Lipopolysachharide
(Pg LPS ) for 4 hours. Also, claudin−1 is upregulated by the
exposure of Pg to gingival epithelial cells after 4 hours
while is significantly downregulated by the chronic exposure
of LPS for 3 weeks. Pg is an opportunistic pathogen which
relies on fermentation of amino acids for metabolic energy
and tends to grow in nutritional environment forming sub-
gingival plaque. Subsequent changes in the local environ-
ment which may be host related factor or symbiotic patho-
gens can differentially regulate its virulence factors. LPS is
the most potent endotoxin which exerts its effect through ac-
tivation of Toll like receptor 4 (TLR4) (Tada et al., 2013).
The studies have shown to activate TLR4 after 6 hours of
LPS exposure to oral epithelial cells. Based on the above re-
sults, we can hypothesize the pathogenesis of Pg in two
ways. In the early stage of infection, epithelial cells, which
are the first line of immune defense, respond strongly to Pg
mediated low grade inflammation. At later stage, virulence
Pathological
condition (Oral)
Proteins Explained Impact References
A. In Vitro study
24 hour Biofilm challenge Claudin−4↑ 24hr challenge with biofilm without ‘red complex’ bac-
teria shows upregulation of Claudin−4 which may
not deliberate any biological relevance.
(Guo et al., 2018)
Pg and Pg LPS induced
alteration of TJ−4hr
i) Pg 4hr− Claudin−4↑,
Claudin−15↓ ;
Pg 72hr− Claudin−1↑
ii) Pg LPS 4hr−
Claudin−4↓, Claudin−15↓,
Occludin↓, Claudin−1↑
Early upregulation of TJ proteins is due to compensa-
tory mechanism for barrier protection.
Chronic exposure of pathogen altered the immune de-
fence mechanism and hence alter TJ expression result-
ing in epithelial disruption.
(Guo et al., 2018 ; Tada et
al., 2019)
Pg induced epithelial disruption
i) >109 bacteria/ml , 2−4hr−
Basolateral exposure− ↓TER




Decreased TER observed between 2−4 hour− Bacterial
pathogen exposed from basolateral surface are more sus-
ceptible for epithelial disruption.
Increase in TER observed up to 24hours and decreased
between 24 − 48 hour − Apical exposure of bacterial
pathogen require more time to induce epithelial disrup-
tions.






ii) No change in expression
Basolateral surfaces are more susceptible than apical
surfaces to the effects of T.denticola and threshold of
bacteria is required to alter epithelial barrier proteins.








Ligation of CD24 facilitates increase expression of TJ
proteins that mediate epithelial barrier functions as a
protective mechanism against periodontal pathogens.
(Ye et al., 2014)
B. In Vivo study
Chronic LPS challenge
periodontitis−3wks
Claudin−1↓ Disruption of barrier functions and initiation of peri-
odontal diseases
(Fujita et al., 2010)
Periodontitis in HIV
patients−5 days treatment of




Activated immune cells produce larger amount of pro-
inflammatory cytokines which disrupt epithelial barriers,





Claudin−3↓,16↓,19−↓ 1) Hypoplastic and hypomineralised tooth.
2) Enamel loss, easily breakable enamel with underlying
dentin exposure in molars, and decreased mineralization
in continuously growing lower incisors in patients with
FHHNC.
(Bardet et al., 2016)
Table 2 : Altered expression of Claudin and Occludin in various oral pathological conditions ; TJ, Tight Junction ; Pg , Porphyromonas
gingivalis ; LPS, Lipopolysaccharide ; FHHNC, Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis ; TER, Transepithe-
lial Electrical Resistance.
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factor like LPS activates TLR4 leading to series of inflam-
matory cascade resulting in tissue destruction (Kocgozlu et
al., 2009).
By the exposure of Treponema denticola (Td ) at a con-
centration of >109 bacteria/ml for 2−4 hours, transepithelial
electrical resistance (TER) is decreased in the basolateral
area, while is increased in the apical area (Katz et al., 2000).
At concentration of 104 bacteria/ml for 6 hours, TER is sig-
nificantly decreased in the basolateral area, while no change
is observed in the apical area. At concentration of 102 bacte-
ria/ml for 16 hours, Claudin−1 is decreased in both apical
and basolateral area (Kikuchi et al. , 2018). These signify
that the disruption of epithelial junctional proteins is caused
by the critical threshold of bacterial load and exposure dura-
tion.
Claudin and occludin maintains barrier integrity from the
early development of tooth germs when ameloblast and
odontoblast differentiates (João & Arana−Chavez, 2004). Fa-
milial hypomagnesaemia with hypercalciuria and nephrocal-
cinosis (FHHNC) is a rare kidney disease caused by the mu-
tation of claudin−16 and −19. These patients show severe
enamel defects, which are similar to amelogenesis imper-
fecta with impaired TJ structure and enamel matrix deposi-
tion. The loss of claudin−16 results in the modification of
environmental factors such as pH, impairment of the proc-
essing of enamel matrix proteins and disturbance of enamel
formation, in the patients with FHHNC and in the Cldn16−/−
mice (Bardet et al., 2016). Claudin−3 and −19 deficiency in
patients with FHHNC presented hypoplastic or hypomineral-
ised enamel in both secretory and maturational stages
(Bardet et al. , 2017). These highlights the importance of
claudin and occludin from early stages of tooth development
Cancer (Skin) Proteins Explained Impact References





↓ (in cell membrane)
Translocalization of claudin away from cell membrane may suggest
endocytosis leading claudin retention in cytoplasmic vesicles which
may lead to altered cell polarity and barrier.
(Arabzadeh et al., 2007)










Increased claudin−1 facilitates invasive potential
Loss of claudin is a biomarker for tumor progression
Claudin−4 and occludin are concentrated around cancer−pearl which
indicates the presence of TJ is not for barrier function rather than
their relation to keratinization.
(Ouban et al., 2012 ;
Nissinen et al., 2017 ;








May express other pathogenetic mechanism to regulate invasion.
Expression of Claudin−7 is late event in epidermal neoplastic process.
Expression of claudin−11 is associated with progression of tumor to
invasive stage.
Downregulated occludin decrease cell−cell adhesion, altered epider-
mal differentiation and calcium homeostasis.
(Ouban et al., 2012 ;
Hintsala et al., 2013 ;
Rachow et al., 2013 ;







The increased expression may signify TJ may play role in self-
isolation of tumor from environment.
Expression of claudin−5 in certain areas signifies the formation
of vessels within tumor mass
(Haass et al., 2003)
Metastatic melanoma Claudin−1↑
Claudin−1↓
Expression of claudin increases MMP−2 activity thereby increasing
melanoma cell motility.
Claudin−1 produced by melanocytes may not assemble with TJ
structures
(Cohn et al., 2005 ;






Diminish TJ barrier functions.
Overexpression of Claudin−2 is associated with leakage of barrier.
Alteration of Claudin−4 is induced by UV radiation
(Hintsala et al., 2013 ;





TJ−associated molecules altered in relation to keratinization
(individual cell keratinization).





Claudin−1↓ Claudin−1 may be a transcriptional target of p63 gene, which has un-
dergone mutation in AEC patients, so its downregulated expression
causes skin fragility.
(Lopardo et al., 2008)
Table 3 : Altered expression of Claudin and Occludin in various skin cancer ; TJ, Tight Junction ; DMBA, Dimethylbenz(a)anthracene ;
TPA, Tetradecanoyl−phorbol−13−acetate.
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in creating suitable environment for enamel deposition and
maturation by their role as barrier maintaining proteins.
Claudin and occludin in cancer of skin and oral
cavity
Cell to cell interaction is important phenomenon in main-
taining tissue integrity and homeostasis. The loss of cell−cell
adhesion is considered as the initiation in the process of in-
vasion and metastasis in carcinoma. The altered expression
of TJ proteins can increase epithelial permeability, loss of
contact inhibition, polarity and abnormal signaling leading to
inhibition or activation of various growths signaling mecha-
nism. Although the exact mechanism of altered TJ proteins
in cancer is still unclear, the involvement can be confirmed
by the deregulated expressions with migration, invasion and
metastasis of cancer in tissue specific manner (Martin & Ji-
ang, 2009). The bewildering expressions of TJ proteins in
various cancers are due to solitary or synergistic actions of
above mechanisms.
The alterations of claudin and occludin in dysplasia and
cancer in skin and oral tissues are shown in Table 3 and Ta-
ble 4 respectively. The expression patterns of TJ proteins
might have some correlation with the type of tumor grade,
site or keratinization.
As ultraviolet (UV) radiation is the major risk factor for
benign and malignant lesion of skin, the effect of UV radia-
tion on TJ proteins may also precede the conditions. The
downregulation of claudin−1 and upregulation of claudin−2
and −4 are shown in the precursor tumors such as atopic
keratosis, and it resulted in diminished TJ barrier function
which is a typical feature of dysplastic lesion (Hintsala et
al., 2013). The expression of claudin−1, −4 and occludin is
altered in Bowen’s disease (Morita et al., 2004). Claudin−1
is upregulated in the early stage of cutaneous squamous cell
carcinoma (cSCC) and is downregulated in advanced stage
(Sappayatosok & Phattarataratip, 2015). Claudin−4 and oc-
cludin are upregulated in well differentiated cSCC, while
their concentrated expression is observed around the keratin
pearl instead of cell − cell border ( Morita et al. , 2011 ) .
Claudin−4 expression is increased in keratinized portion of
SCC whereas downregulated in non − keratinized part
(Vicente et al., 2015). The expression of claudin−7 and −11
is upregulated in undifferentiated cutaneous SCC, and is
more significantly upregulated in the later event in epider-
mal neoplastic process (Hintsala et al 2013 ; Nissinen et al.,
2018). The decreased expression of occludin is shown in
other carcinoma derived from non−keratinized epithelia such
as hepatic carcinoma, gastric carcinoma, breast carcinoma
and endometrial carcinoma (Sawada et al., 2003). This indi-
cates that TJ proteins might be related to keratinization.
Furthermore, the summary of TJ proteins in other skin
carcinoma such as malignant melanoma (MM) and merkel
cell carcinoma (MCC) have been studied. Loss of Claudin−1
in metastatic MM (MMM) as compared to benign melano-






May involve other regulating factors than claudin to increase invasive
potential.
Claudin overexpression result in enhanced cell adhesion and de-
creased tumor aggressiveness. Upregulation may interfere with TJ in-
teractions and signaling cascades
(Joãoj & Arana−Chavez,
2004 ; De Vicente et al.,







Claudin−1 enhances tumor invasion by degradation of extracellular
matrix deposition.
Claudin−4 play a role in maintaining the architecture of cell nests and
keratin pearls, however downregulation is accompanied with decrease
e− cadherin expression which enhance migration, invasiveness and
metastasis
Loss of Claudin−7 directly promote neoplastic process due to destruc-
tion of TJ
(Joãoj & Arana−Chavez,
2004 ; Oku et al., 2006 ;
El−Bolok, 2011 ; De








Increased in an attempt to maintain cell–cell attachments at the sites
of cystic degeneration.
Over expression of Claudin−4 in keratinocytes surface may be associ-
ated with abnormal TJs formation.
May play a role in the formation of Rushton hyaline bodies.






Claudin−5 is the only claudin member expressed in endothelium.
Subcellular localization of Claudin− 7 in lining epithelium may result
in formation of Rushton hyaline bodies.




Claudin−1↓ Staining intensity increasing with high grade of tumor may suggest
the involvement of claudin−1 in progression of dysplasia
(Kwon, 2013 ;
Carvalho et al., 2010)
Table 4 : Altered expression of Claudin and Occludin in various oral diseases ; TJ, Tight Junction ; OSCC, Oral Squamous Cell Carci-
noma ; KCOT ; Keratocystic Odontogenic Tumour
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cytic nevi may be due to failure of claudin produced by
melanocytes cells to assemble with TJ structures (Cohn et
al., 2005). In experimentally induced skin papilloma of mice
with 7, 12−dimethylbenz (a) anathracene, the downregulated
expression of claudin−1, −6, −11, −12, −18 is observed. The
downregulation of TJ proteins may be due to the involve-
ment of transcriptional factors silencing the expression of
claudin (Arabzadeh & Turksen., 2007).
The expression of claudin and occludin depends on the
histopathological grade of cancer. Claudin−1, −4 and −7 are
the major TJ proteins altered in oral cancer. In mild epithe-
lial dysplasia and early stage of Oral SCC (OSCC), the ex-
pression of claudin−1 is downregulated, thereby leading to
the disorganization of epithelial cancer cells. The low ex-
pression of claudin−1 may be a predictor of disease recur-
rence and poor prognosis. The increased expression of
claudin−1 with cancer progression enhances the invasive po-
tential with degradation of extracellular matrix. Claudin−4
and −7 are upregulated in the early stages of OSCC and are
downregulated in the late stages. The upregulation in the
early stages interferes with TJ functioning and signaling
whereas the downregulation in the late stages is accompa-
nied with the destruction of TJ structure enhancing migra-
tion, invasion and metastasis. The expression of TJ proteins
in the lining epithelium of keratocystic odontogenic tumor
(KCOT) is found to be associated with keratinization. The
concentrated presence of claudin−1, −3, −4 is found in the
area of keratin pearls. The increased expression of claudin−1
is associated with compensatory mechanism to maintain bar-
rier integrity. The increased expression of claudin−4 and −7
is found to be associated with their role in Rushton hyaline
body formation. The loss of claudin−3 caused the altered
barrier formation and the loss of cell polarity which simulate
the biological behavior of KCOT. Claudin−5 is only ob-
served in the vascular lining of KCOT. Claudin−5 is the
only protein of claudin family expressed in the endothelium.
Similarly the upregulation of claudin−1 in the invasive duc-
tal breast, cervical and colorectal carcinoma, and the down-
regulation of claudin−4 and −7 in the invasive esophageal
and prostrate carcinoma are observed. Also the downregula-
tion of claudin−1 in other invasive carcinomas such as hepa-
tocellular and prostate carcinoma is observed.
The role of claudin and occludin in tumorigenesis is com-
plicated. The impaired cell−cell contacts leading to series of
changes with its reduced expression are clearly understand-
able, but the overexpression of certain proteins in many me-
tastatic lesions creates paradigm that how stabilizing proteins
enhances cell motility of tumor cells. The alteration of TJ
functions is caused by either underexpression or overexpres-
sion of TJ proteins. The transcriptional regulator should be
taken into consideration. Decreased expression leading to
cell detachment process is understandable but increased ex-
pression of claudins are often observed in tumor cells. The
enhanced expression may also be an initial step which dis-
turbs the balance of TJ in the cells and is associated with
proliferation, invasion and metastasis of the tumor cells. The
expression of TJ proteins for carcinomas are not consistent.
These may be due to multifactorial complex where TJ per-
forms barrier function, cellular signaling and differentiation.
These may act through specific pathway to potentiate or pro-
tect tumorigenesis.
TJ proteins in skin and oral mucosa with aging
Aging is a progressive decline in the physiological func-
tion leading to onset of organ specific functional deteriora-
tion. The clinical presentation of aged skin exhibit hypo−/
hyper−pigmented lesions, wrinkle scaly appearances or pal-
lor fragility. Some studies have attributed these changes to
the change of thickness in the stratum corneum composition
and basement membrane (Farage et al., 2013), while another
study highlighted the role of TJ (Bhattacharyya & Thomas,
2004). The intrinsic factor for aging changes is due to the
continuous physiological remodeling of tissues which was
generated by some stresses over time period ( Quan &
Fisher, 2015). The accumulation of reactive oxygen species
(ROS) causing stress to cells is led by the extrinsic factors
such as UV radiation, pollution, smoking, hypoxia, or poor
nutrition. These oxidative stresses may lead to the post−
translation mostly including phosphorylation at serine and
threonine residues, and may result in altering the phospho-
rylation pattern and the barrier integrity.
Few Studies have been reported regarding the expression
and regulation of TJ proteins in skin and oral mucosa with
physiological and experimental models of aging skin. In a
study, no significant alteration of TJ proteins in human
young or intrinsically aged epidermis is confirmed even
though the decreased expression is confirmed in rodent epi-
dermis (Althubaiti., 2012). However, the changes in barrier
functions and TEWL are noted in physiologically aged skin.
This might be due to the various signaling pathway associ-
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ated with TJ proteins. In an experimental model of aging
skin, claudin−1 is downregulated, and claudin−7 and −12
are upregulated in the photoaged skin as compared to the
photoprotected skin ( Althubaiti, 2012 ) . The UV radiation
may change TJ protein levels by ROS mediated signaling
associated with degradation of MMP or directly affecting the
genes at the transcriptional level. The barrier disruption is
caused by the downregulation of claudin−1 and upregulation
of claudin−7 and −12. The wrinkled skin with increased
TEWL caused by the downregulation of claudin−1 is ob-
served in the aging mice (Parrish., 2017). These changes are
accompanied by the marked downregulation of claudin−1.
The epidermal barrier disruption is shown by the claudin−1
knockdown aged mice with atopic dermatitis as compared to
claudin+/+mice (Tokumasu et al., 2017). Normal morphologi-
cal phenotype is shown by the transgenic mice overexpress-
ing an epidermal targeted claudin−6 at a young age, while
severe dermatitis associated skin barrier function is shown
by a high sensitivity for epidermal injury with aging (Troy
et al., 2009).
In aging mice, Claudin−2, −3, −4 and −5 are downregu-
lated in the kidney epithelium and pancreas. Claudin−1 is
upregulated in the liver and kidney and claudin−7 is upregu-
lated in the pancreas (D’Souza et al., 2009). Although the
exact mechanism and regulation of their expression in aging
tissue are still not clear, these are considered as the effect on
TJ functionality which is responsible for some of the aging
related changes.
Conclusion
TJ proteins, including mainly claudin and occludin, plays
a major role in maintaining epithelial integrity. The altered
expression, of these proteins are responsible for skin and
oral diseases. The role of these proteins in various carcino-
mas is crucial in the invasion and metastasis. The under-
standing of altered expression of these proteins in the age−
related diseases is important and studies are limited. Further
research is needed to be focused on this aspect.
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